H. Aikata

Lenvatinib activates potential anti-tumor immunity by increasing infiltration of immune cells and interferon response in tumor microenvironment of advanced hepatocellular carcinoma

Background It has been reported that the combination of lenvatinib, a multiple receptor tyrosine kinase inhibitor, and an immune checkpoint inhibitor enhances the antitu...

H. Nelson ;

Y. Kato ;

M. Kimura ;

M. Yamauchi ;

N. Suzuki ;

A. Ono ;

H. Aikata ;

K. Amioka ;

K. Chayama ;

Y. Fujii ;

S. Uchikawa ;

H. Fujino ;

T. Nakahara ;

E. Murakami ;

W. Okamoto ;

T. Kawaoka ;

D. Miki ;

M. Tsuge ;

M. Imamura ;

06/27/2022

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

H. Aikata

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products